Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
J Pharm Sci ; 107(9): 2315-2324, 2018 09.
Article in English | MEDLINE | ID: mdl-29751008

ABSTRACT

We have used hydrogen exchange-mass spectrometry to characterize local backbone flexibility of 4 well-defined IgG1-Fc glycoforms expressed and purified from Pichia pastoris, 2 of which were prepared using subsequent in vitro enzymatic treatments. Progressively decreasing the size of the N-linked N297 oligosaccharide from high mannose (Man8-Man12), to Man5, to GlcNAc, to nonglycosylated N297Q resulted in progressive increases in backbone flexibility. Comparison of these results with recently published physicochemical stability and Fcγ receptor binding data with the same set of glycoproteins provide improved insights into correlations between glycan structure and these pharmaceutical properties. Flexibility significantly increased upon glycan truncation in 2 potential aggregation-prone regions. In addition, a correlation was established between increased local backbone flexibility and increased deamidation at asparagine 315. Interestingly, the opposite trend was observed for oxidation of tryptophan 277 where faster oxidation correlated with decreased local backbone flexibility. Finally, a trend of increasing C'E glycopeptide loop flexibility with decreasing glycan size was observed that correlates with their FcγRIIIa receptor binding properties. These well-defined IgG1-Fc glycoforms serve as a useful model system to identify physicochemical stability and local backbone flexibility data sets potentially discriminating between various IgG glycoforms for potential applicability to future comparability or biosimilarity assessments.


Subject(s)
Chemistry, Pharmaceutical/methods , Immunoglobulin Fc Fragments/chemistry , Immunoglobulin G/chemistry , Tandem Mass Spectrometry/methods , Glycosylation , Humans , Immunoglobulin Fc Fragments/analysis , Immunoglobulin Fc Fragments/metabolism , Immunoglobulin G/analysis , Immunoglobulin G/metabolism , Mass Spectrometry/methods , Pichia , Pliability , Protein Structure, Secondary , Protons
2.
J Pharm Sci ; 105(2): 559-574, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26869419

ABSTRACT

Four different well-defined IgG1 Fc glycoforms are proposed as a model system to examine important biological and physicochemical features for protein drug biosimilar analyses. The IgG1 Fc glycoforms were produced by yeast expression combined with in vitro enzymatic synthesis as a series of sequentially truncated high-mannose IgG1 Fc glycoforms with an anticipated range of biological activity and structural stability. Initial characterization with mass spectrometry, SDS-PAGE, size exclusion HPLC, and capillary isoelectric focusing confirmed that the glycoproteins are overall highly similar with the only major difference being glycosylation state. Binding to the activating Fc receptor, FcγRIIIa was used to evaluate the potential biological activity of the IgG1 Fc glycoproteins. Two complementary methods using biolayer interferometry, 1 with protein G-immobilized IgG1 Fc and the other with streptavidin-immobilized FcγRIIIa, were developed to assess FcγRIIIa affinity in kinetic binding studies. The high-mannose IgG1 Fc and Man5-IgG1 Fc glycoforms were highly similar to one another with high affinity for FcγRIIIa, whereas GlcNAc-Fc had weak affinity, and the nonglycosylated N297Q-Fc had no measurable affinity for FcγRIIIa. These 4 IgG1 Fc glycoforms were also evaluated in terms of physical and chemical stability profiles and then used as a model system to mathematically assess overall biosimilarity, as described in a series of companion articles.


Subject(s)
Biosimilar Pharmaceuticals/chemical synthesis , Chemistry, Pharmaceutical/methods , Glycoproteins/chemical synthesis , Immunoglobulin Fc Fragments/chemistry , Immunoglobulin G/chemistry , Biosimilar Pharmaceuticals/metabolism , Drug Evaluation, Preclinical/methods , Glycoproteins/analysis , Glycoproteins/metabolism , Glycosylation , Immunoglobulin Fc Fragments/analysis , Immunoglobulin Fc Fragments/metabolism , Immunoglobulin G/analysis , Immunoglobulin G/metabolism , Protein Binding/physiology
3.
J Pharm Sci ; 105(2): 575-587, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26869420

ABSTRACT

As part of a series of articles in this special issue evaluating model IgG1-Fc glycoforms for biosimilarity analysis, 3 well-defined IgG1-Fc glycoforms (high mannose-Fc, Man5-Fc, and N-acetylglucosamine-Fc) and a nonglycosylated Fc protein (N297Q-Fc) were examined in this work to elucidate chemical degradation pathways. The 4 proteins underwent a combination of accelerated thermal stability studies and 4 independent forced degradation studies (UV light, metal-catalyzed oxidation, peroxyl radicals, and hydrogen peroxide) at pH 6.0. Our results highlight chemical degradations at Asn315, Met428, Trp277, and Trp313. A cross-comparison of the different Fc glycoforms, stress conditions, and the observed chemical reactions revealed that both the deamidation of Asn315 and the transformation of Trp277 into glycine hydroperoxide were glycan dependent during incubation for 3 months at 40 °C. Our data will show that different glycans not only affect chemical degradation differently but also do lead to different impurity profiles, which can affect chemical degradation.


Subject(s)
Glycoproteins/chemistry , Immunoglobulin Fc Fragments/chemistry , Immunoglobulin G/chemistry , Drug Evaluation, Preclinical/methods , Drug Stability , Glycoproteins/metabolism , Glycosylation , Immunoglobulin Fc Fragments/metabolism , Immunoglobulin G/metabolism
4.
J Pharm Sci ; 105(2): 588-601, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26869421

ABSTRACT

As part of a series of articles in this special issue describing 4 well-defined IgG1-Fc glycoforms as a model system for biosimilarity analysis (high mannose-Fc, Man5-Fc, GlcNAc-Fc and N297Q-Fc aglycosylated), the focus of this work is comparisons of their physical properties. A trend of decreasing apparent solubility (thermodynamic activity) by polyethylene glycol precipitation (pH 4.5, 6.0) and lower conformational stability by differential scanning calorimetry (pH 4.5) was observed with reducing size of the N297-linked oligosaccharide structures. Using multiple high-throughput biophysical techniques, the physical stability of the Fc glycoproteins was then measured in 2 formulations (NaCl and sucrose) across a wide range of temperatures (10°C-90°C) and pH (4.0-7.5) conditions. The data sets were used to construct 3-index empirical phase diagrams and radar charts to visualize the regions of protein structural stability. Each glycoform showed improved stability in the sucrose (vs. salt) formulation. The HM-Fc and Man5-Fc displayed the highest relative stability, followed by GlcNAc-Fc, with N297Q-Fc being the least stable. Thus, the overall physical stability profiles of the 4 IgG1-Fc glycoforms also show a correlation with oligosaccharide structure. These data sets are used to develop a mathematical model for biosimilarity analysis (as described in a companion article by Kim et al. in this issue).


Subject(s)
Glycoproteins/chemistry , Immunoglobulin Fc Fragments/chemistry , Immunoglobulin G/chemistry , Oligosaccharides/chemistry , Drug Stability , Glycosylation , Polyethylene Glycols/chemistry , Protein Conformation
SELECTION OF CITATIONS
SEARCH DETAIL
...